摘要
从中外指南比较的角度,介绍中国新指南的基本特点和内容要点。包括对于慢性心力衰竭可改善预后的药物及可能有害的药物。醛固酮拮抗剂及心脏再同步化治疗应用扩大至NYHAⅡ级患者。对于心衰的定义、阶段划分、药物应用的时机和适应证,以及心力衰竭一些新诊治手段的评价。
From the Chinese and foreign guide angle,introduces the basic characteristics and main contents of the new chi nese chronic heart failure guideline. Including to improve the prognosis of drug and potentially harmful drugs for chronic heart failure. Aldosterone antagonist and application of cardiac resynchronization therapy to expand to NYHA Ⅱ patients.For the definition of heart failure,stage division,drug application timing and indications,evaluation and some new methods of diagnosis and treatment of heart failure.
出处
《中国实用内科杂志》
CAS
CSCD
北大核心
2014年第7期662-665,共4页
Chinese Journal of Practical Internal Medicine
关键词
心力衰竭
指南
heart failure
guideline